Company: RETO
Filing Date: 2025-07-31
Form Type: F-3
Source: 0001213900-25-070052
Chunk: 30

Company: ReTo Eco-Solutions, Inc.
Filing Date: 2025-07-31
Form: F-3
Chunk 30
---
 to, follow-on offerings, secondary listings and going private transactions, will be subject to the filing requirements
with the CSRC under the Trial Measures. As of the date of this prospectus, we have not received any formal inquiry, notice, warning, sanction,
or objection from the CSRC or any other PRC governmental authorities with respect to our listing on Nasdaq. The filing for the MeinMalzeBier
Acquisition (as defined below) has been submitted and is under review. The Company is in the process of preparing for the filing for the
Offering. As the Trial Measures were newly published and there is uncertainty with respect to the filing requirements and their
implementation, we cannot be sure that we will be able to complete such filings in a timely manner, or at all. Any failure or perceived
failure of us to fully comply with such new regulatory requirements could significantly limit or completely hinder our ability to offer
or continue to offer securities to investors, cause significant disruption to our business operations, and severely damage our reputation,
which could materially and adversely affect our financial condition and results of operations and could cause the value of our securities
to significantly decline or be worthless. See “Item 3. Key Information — D. Risk Factors — Risks Related to Doing Business in China — Approval of the CSRC or other PRC government authorities may be required in connection with our future offerings under PRC law, and if required, we cannot predict whether or for how long we will be able to obtain such approval” in our 2024
Annual Report, which is incorporated by reference into this prospectus.

As of the date of this prospectus,
except as disclosed above, neither ReTo nor any of our PRC subsidiaries, (i) is required to obtain permissions from the PRC authorities,
including the CSRC or the CAC, in connection with our issuance of securities to foreign investors, or (ii) has been denied such permissions
by any PRC authority. We are subject to the risks of uncertainty of any future actions of the PRC government in this regard including
the risk that we inadvertently conclude that the permission or approvals discussed here are not required, that applicable laws, regulations
or interpretations change such that we and our PRC subsidiaries are required to obtain approvals in the future.

Recent Developments

Divestiture in December 2024

On December 30, 2024, ReTo
entered into a Share Sale Agreement with Zhao Duan Wen, pursuant to which the Company agreed to sell